Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerzy Jankun

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Experimental and Therapeutic Medicine|July 11, 2015
Enamel matrix proteins exhibit growth factor activity: A review of evidence at the cellular and molecular levelsMarzena Wyganowska-Świątkowska, Paulina Urbaniak, Michał Marek Nohawica, et al.
International Journal of Molecular Medicine|June 7, 2003
Structure of curcumin in complex with lipoxygenase and its significance in cancerEwa Skrzypczak-Jankun, Kangjing Zhou, N Patrick McCabe, et al.
Oncology Reports|November 18, 2004
Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cellsJoanna Chorostowska-Wynimko, Rafal Swiercz, Ewa Skrzypczak-Jankun, et al.
BJU International|May 17, 2005
Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapyJerzy Jankun, Rick W Keck, Ewa Skrzypczak-Jankun, et al.
International Journal of Molecular Medicine|December 17, 2008
VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active formJerzy Jankun, Ansari M Aleem, Steve H Selman, et al.
International Journal of Molecular Medicine|November 1, 2013
Complex interaction between the immune system and adipose tissue (Review)Sylwia Małgorzewicz, Jolanta Anna Dardzińska, Maria Gnacińska, et al.
International Journal of Molecular Medicine|February 11, 2011
Diverse inhibition of plasminogen activator inhibitor type 1 by theaflavins of black teaJerzy Jankun, Magdalena Skotnicka, Wiesława Łysiak-Szydłowska, et al.
Central-European Journal of Immunology|August 24, 2018
Can components of the plasminogen activation system predict the outcome of kidney transplants?Jerzy Jankun, Omar A Khan, Hesham I Mostafa, et al.
Current Molecular Medicine|December 17, 2008
Do human lipoxygenases have a PDZ regulatory domain?Jerzy Jankun, Tobias Doerks, Ansari M Aleem, et al.
International Journal of Molecular Medicine|April 16, 2016
Clinical implications of the growth-suppressive effects of chlorhexidine at low and high concentrations on human gingival fibroblasts and changes in morphologyMarzena Wyganowska-Swiatkowska, Malgorzata Kotwicka, Paulina Urbaniak, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Experimental and Therapeutic Medicine|July 11, 2015
Enamel matrix proteins exhibit growth factor activity: A review of evidence at the cellular and molecular levelsMarzena Wyganowska-Świątkowska, Paulina Urbaniak, Michał Marek Nohawica, et al.
International Journal of Molecular Medicine|June 7, 2003
Structure of curcumin in complex with lipoxygenase and its significance in cancerEwa Skrzypczak-Jankun, Kangjing Zhou, N Patrick McCabe, et al.
Oncology Reports|November 18, 2004
Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cellsJoanna Chorostowska-Wynimko, Rafal Swiercz, Ewa Skrzypczak-Jankun, et al.
BJU International|May 17, 2005
Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapyJerzy Jankun, Rick W Keck, Ewa Skrzypczak-Jankun, et al.
International Journal of Molecular Medicine|December 17, 2008
VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active formJerzy Jankun, Ansari M Aleem, Steve H Selman, et al.
International Journal of Molecular Medicine|November 1, 2013
Complex interaction between the immune system and adipose tissue (Review)Sylwia Małgorzewicz, Jolanta Anna Dardzińska, Maria Gnacińska, et al.
International Journal of Molecular Medicine|February 11, 2011
Diverse inhibition of plasminogen activator inhibitor type 1 by theaflavins of black teaJerzy Jankun, Magdalena Skotnicka, Wiesława Łysiak-Szydłowska, et al.
Central-European Journal of Immunology|August 24, 2018
Can components of the plasminogen activation system predict the outcome of kidney transplants?Jerzy Jankun, Omar A Khan, Hesham I Mostafa, et al.
Current Molecular Medicine|December 17, 2008
Do human lipoxygenases have a PDZ regulatory domain?Jerzy Jankun, Tobias Doerks, Ansari M Aleem, et al.
International Journal of Molecular Medicine|April 16, 2016
Clinical implications of the growth-suppressive effects of chlorhexidine at low and high concentrations on human gingival fibroblasts and changes in morphologyMarzena Wyganowska-Swiatkowska, Malgorzata Kotwicka, Paulina Urbaniak, et al.
Pageof 7